
Please contact the doctor's office to verify that your insurance is accepted.
Dr. Kamel is the Helen and Albert Moon Professor, Chief of Neurocritical Care, and Vice Chair for Research in the Department of Neurology at Weill Cornell Medicine. He also directs the Clinical and Translational Neuroscience Unit in the Feil Family Brain and Mind Research Institute at Weill Cornell Medicine. Dr. Kamel attended college at Harvard and medical school at Columbia, then trained as a neurology resident and neurocritical care fellow at UCSF before joining Weill Cornell Medicine in 2011. He has published over 450 scientific papers, including in leading journals such as NEJM and JAMA. He was a principal investigator for the NIH-funded ARCADIA trial, which tested antithrombotic str...
Prolonged QT interval and risk of recurrent stroke in the Atrial Cardiopathy and Antithrombotic Drugs in Prevention After Cryptogenic Stroke (ARCADIA) trial.
Contemporary US Practice Patterns Regarding Anticoagulation and LAA Closure in ICH Survivors With Atrial Fibrillation.
Emergency Department Visits for Falls and First-Time Seizure.